Iperoxo

TargetMol
Product Code: TAR-T25538
Supplier: TargetMol
CodeSizePrice
TAR-T25538-1mg1mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-5mg5mg£158.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-1mL1 mL * 10 mM (in DMSO)£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-10mg10mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-25mg25mg£418.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-50mg50mg£589.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-100mg100mg£809.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25538-500mg500mg£1,564.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Iperoxo is an agonist of Muscarinic AChR and can be used to probe activation-related conformational transitions of muscarinic receptors.
CAS:
247079-84-1
Formula:
C10H17IN2O2
Molecular Weight:
324.16
Pathway:
Neuroscience
Purity:
0.9893
SMILES:
[I-].C(#CC[N+](C)(C)C)COC1=NOCC1
Target:
AChR

References

1. Jim?nez-Ros?s M, et al. Ligand-Triggered Structural Changes in the M(2) Muscarinic Acetylcholine Receptor. J Chem Inf Model. 2018 May 29;58(5):1074-1082. 2. Fish I, et al. Structure-Based Design and Discovery of New M(2) Receptor Agonists. J Med Chem. 2017 Nov 22;60(22):9239-9250. 3. Schrage R, et, al. Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor. Br J Pharmacol. 2013 May;169(2):357-70. 4. Schrage R, et, al. New insight into active muscarinic receptors with the novel radioagonist [?H]iperoxo. Biochem Pharmacol. 2014 Aug 1;90(3):307-19.